Enzymatic Therapy and University of Maryland scientist file lawsuits against five natural product industry manufacturers.Enzymatic Therapy (Green Bay, WI; 920-469-1313) and Abulkalam M. Shamsuddin, MD, PhD filed Complaints with the United States District Court for the District of Maryland The United States District Court for the District of Maryland is the Federal district court whose jurisdiction is the state of Maryland.
Notable judges in this district include William Paca, a signer of the United States Declaration of Independence. against Solaray, Inc., and its parent, Nutraceutical International Corporation, BNG BNG Bangladesh
BNG Bloque Nacionalista Galego (Galician Nationalist Bloc, Spain)
BNG Bank Nederlandse Gemeenten
BNG Bump & Grind
BNG Bob and George (webcomic)
BNG Bermuda National Gallery Enterprises, Inc.; Jarrow Formulas, Inc.; Lifesource Naturals; and Water Pure, Inc. doing business as Purity Products.
The Complaints allege that each of these defendants has directly infringed, contributorily infringed and/or actively induced the infringement of one or more claims of United States Patent 5,082,833, entitled "Reduction of Cell Proliferation and Enhancement of NK-Cell Activity," in marketing and selling their IP-6 products. Dr. Shamsuddin is the inventor and owner of the '833 patent and Enzymatic Therapy is the exclusive licensee under the patent. The Enzymatic Therapy product covered by the '833 patent is marketed under the name "Cell Forte with IP-6 and Inositol inositol (ĭnō`sĭtōl): see vitamin.
The generic name for hexahydroxycyclohexanes, which are classified as carbohydrates. ."
The Complaints against Solaray and Nutraceutical, Jarrow Formulas, Lifesource Naturals and Water Pure further allege unfair competition in violation of federal law and invasion of the right to privacy under Maryland law, based in part on these companies' unauthorized use of Dr. Shamsuddin's name and reputation in marketing and advertising their IP-6 products. The Plaintiffs also allege that Solaray has made unauthorized use of Enzymatic Therapy's copyrighted materials in promoting its product.
The Complaints filed by Dr. Shamsuddin and Enzymatic Therapy seek an injunction, compensatory damages A sum of money awarded in a civil action by a court to indemnify a person for the particular loss, detriment, or injury suffered as a result of the unlawful conduct of another. , and increased and/or punitive damages based on the defendants' willful and deliberate unlawful conduct. Dr. Shamsuddin and Enzymatic Therapy intend to bring additional actions to the extent necessary to protect their patent, copyright, and other intellectual property rights.
Dr. Shamsuddin is a professor of pathology at The University of Maryland University of Maryland can refer to:
The production of cancer.
production of cancer.
viruses and some parasites are capable of initiating neoplasia. and inositol phosphates.
Enzymatic Therapy is an FDA-registered manufacturer of over 200 natural medicines, nutritional supplements, vitamins and herbal extracts. The company was the first to introduce Ginkgo biloba, glucosamine glucosamine /glu·co·sa·mine/ (gloo-ko´sah-men) an amino derivative of glucose, occurring in glycosaminoglycans and a variety of complex polysaccharides such as blood group substances. sulfate sulfate, chemical compound containing the sulfate (SO4) radical. Sulfates are salts or esters of sulfuric acid, H2SO4, formed by replacing one or both of the hydrogens with a metal (e.g., sodium) or a radical (e.g., ammonium or ethyl). and the standardization of botanicals to the United States health market. Enzymatic Therapy distributes its product line to health food stores nationwide.